Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on October 1, 2025, covering events occurring on September 28, 2025. The filing details a material definitive agreement involving a private placement financing transaction.
Key Financial Metrics and Transaction Details
- Transaction Type: Private Placement (PIPE Financing) with Brown Stone Capital Limited.
- Securities Issued: 161,583 shares of Common Stock and 479,442 Pre-Funded Warrants.
- Purchase Price: $1.56 per share for Common Stock; $1.5599 per Pre-Funded Warrant ($1.56 minus $0.0001).
- Use of Proceeds: Working capital, general corporate purposes, and repayment of existing convertible notes.
- Financial Metrics: The filing does not provide specific revenue, profit, cash flow, margin, or total debt figures for the reporting period.
Material Changes
The primary material change is the entry into a Securities Purchase Agreement to raise capital. The company agreed to issue equity and pre-funded warrants to an accredited investor. Additionally, the company committed to filing a registration statement on Form S-3 by October 9, 2025, to register the resale of these securities.
Outlook, Risks, and Management Commentary
Management intends to utilize the proceeds to strengthen liquidity for working capital and to reduce debt obligations by repaying existing convertible notes. The Pre-Funded Warrants are exercisable immediately upon closing. The offering was conducted under exemptions from registration pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the closing date and actual receipt of proceeds from the Brown Stone Capital Limited transaction.
- Confirm the specific amount of existing convertible notes being repaid with the proceeds.
- Monitor the timely filing of the Form S-3 registration statement by the October 9, 2025 deadline.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for covenants or restrictions not summarized in the 8-K.